A regimen involving the company’s shot failed a Phase 3 trial “by a hair,” an executive said, leading the company to believe ...

With a strong launch underway for a bladder cancer gene therapy, Ferring Pharmaceuticals is finding the kind of commercial ...

The drug, ianalumab, met its objectives in two Phase 3 studies in Sjögren’s syndrome, boosting the outlook of a ...

The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many ...

The complex settlement, which hands payouts and royalties to CureVac and partner GSK, comes as BioNTech is inching toward an ...

The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its ...

The investment, which the foundation says is its largest in women’s health, will support research in maternal health, ...

The biotech industry needs to be supported by the government, by Congress,” Pfizer’s Albert Bourla told investors Tuesday in ...

A potentially billion-dollar acquisition of Gilgamesh Pharmaceuticals suggests big pharma may finally be willing to place ...

The company formerly known a Sosei Heptares unveiled new weight loss programs. Elsewhere, BridgeBio and Madrigal unveiled ...

Frazier was among the most active venture investors in 2024, according to analysts at William Blair, backing 17 private life ...

An executive order President Trump signed Thursday codifies rates for over 60 trading partners, including Switzerland. A ...